Jpmorgan Chase & CO Enovis Corp Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Enovis Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 190,523 shares of ENOV stock, worth $8.37 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

190,523

Previous 300,190 36.53%

Holding current value

$8.37 Million

Previous $13.6 Million 39.55%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$40.57 - $48.1 $4.45 Million - $5.27 Million	-109,667 Reduced 36.53%	190,523 $8.2 Million
Q2 2024 Aug 12, 2024	BUY	$44.56 - $62.43 $3.64 Million - $5.09 Million	81,595 Added 37.33%	300,190 $13.6 Million
Q1 2024 May 10, 2024	BUY	$55.44 - $63.8 $2.66 Million - $3.07 Million	48,064 Added 28.18%	218,595 $13.7 Million
Q4 2023 Feb 12, 2024	BUY	$43.67 - $57.07 $1.38 Million - $1.8 Million	31,627 Added 22.77%	170,531 $9.55 Million
Q3 2023 Nov 14, 2023	SELL	$51.65 - $65.54 $338,927 - $430,073	-6,562 Reduced 4.51%	138,904 $7.32 Million
Q2 2023 Aug 11, 2023	SELL	$52.7 - $64.12 $39,525 - $48,090	-750 Reduced 0.51%	145,466 $9.33 Million
Q1 2023 May 18, 2023	BUY	$49.5 - $65.92 $4.05 Million - $5.4 Million	81,893 Added 127.32%	146,216 $7.82 Million
Q1 2023 May 11, 2023	SELL	$49.5 - $65.92 $2.12 Million - $2.82 Million	-42,851 Reduced 39.98%	64,323 $3.44 Million
Q4 2022 Feb 13, 2023	SELL	$44.83 - $57.43 $493,488 - $632,189	-11,008 Reduced 9.31%	107,174 $5.74 Million
Q3 2022 Nov 14, 2022	BUY	$46.07 - $60.1 $777,523 - $1.01 Million	16,877 Added 16.66%	118,182 $5.44 Million
Q2 2022 Aug 11, 2022	BUY	$55.0 - $70.47 $5.57 Million - $7.14 Million	101,305 New	101,305 $5.57 Million

Others Institutions Holding ENOV

# of Institutions

310

Shares Held

60.2M

Call Options Held

1.68M

Put Options Held

693K

View Full List

About Enovis CORP

Ticker ENOV
Exchange NYSE
Sector Industrials
Industry Specialty Industrial Machinery
Shares Outstandng 54,129,500
Market Cap $2.38B
Description
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...

More about ENOV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Enovis Corp Transaction History